Gene Activity List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 64 of 1714:
54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74
Gene Compound Assay Inh Ic50 Ki View
calcium channel, voltage-dependent, beta 4 subunit SILDENAFIL Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit SILDENAFIL Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit SILDENAFIL Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit SILDENAFIL Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit SILDENAFIL Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit SILDENAFIL Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit SILDENAFIL Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit SILDENAFIL Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit SILDENAFIL Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit SILDENAFIL Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit SILDENAFIL Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 SILDENAFIL Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
adrenergic receptor, beta 3 METERGOLINE Adrenergic beta3 54% NoneNone NoneNone View
dopamine receptor D4 PERGOLIDE Dopamine D4.2 54% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 GUANETHIDINE Calcium Channel Type L, Benzothiazepine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 GUANETHIDINE Calcium Channel Type L, Benzothiazepine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 GUANETHIDINE Calcium Channel Type L, Benzothiazepine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 GUANETHIDINE Calcium Channel Type L, Benzothiazepine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 GUANETHIDINE Calcium Channel Type L, Benzothiazepine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 GUANETHIDINE Calcium Channel Type L, Benzothiazepine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 GUANETHIDINE Calcium Channel Type L, Benzothiazepine 54% NoneNone NoneNone View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide PREGNENOLONE-16ALPHA-CARBONITRILE Sodium Channel, Site 2 53% 24.848uM 22.278uM View
sodium channel, voltage-gated, type XI, alpha PREGNENOLONE-16ALPHA-CARBONITRILE Sodium Channel, Site 2 53% 24.848uM 22.278uM View
sodium channel, nonvoltage-gated 1, gamma PREGNENOLONE-16ALPHA-CARBONITRILE Sodium Channel, Site 2 53% 24.848uM 22.278uM View
sodium channel, nonvoltage-gated 1, delta PREGNENOLONE-16ALPHA-CARBONITRILE Sodium Channel, Site 2 53% 24.848uM 22.278uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) PREGNENOLONE-16ALPHA-CARBONITRILE Sodium Channel, Site 2 53% 24.848uM 22.278uM View
sodium channel, nonvoltage-gated 1 alpha PREGNENOLONE-16ALPHA-CARBONITRILE Sodium Channel, Site 2 53% 24.848uM 22.278uM View
sodium channel, voltage-gated, type X, alpha PREGNENOLONE-16ALPHA-CARBONITRILE Sodium Channel, Site 2 53% 24.848uM 22.278uM View
sodium channel, voltage-gated, type IX, alpha PREGNENOLONE-16ALPHA-CARBONITRILE Sodium Channel, Site 2 53% 24.848uM 22.278uM View
sodium channel, voltage gated, type VIII, alpha PREGNENOLONE-16ALPHA-CARBONITRILE Sodium Channel, Site 2 53% 24.848uM 22.278uM View
sodium channel, voltage-gated, type VII, alpha PREGNENOLONE-16ALPHA-CARBONITRILE Sodium Channel, Site 2 53% 24.848uM 22.278uM View
mitogen activated protein kinase 14 BETA-NAPHTHOFLAVONE Protein Serine/Threonine Kinase, p38alpha 53% NoneNone NoneNone View
mitogen-activated protein kinase 14 BETA-NAPHTHOFLAVONE Protein Serine/Threonine Kinase, p38alpha 53% NoneNone NoneNone View
cholinergic receptor, muscarinic 2 SULOCTIDIL Muscarinic M2 53% NoneNone NoneNone View
dopamine receptor D4 PERHEXILINE Dopamine D4.2 53% NoneNone NoneNone View
tachykinin receptor 1 IODOQUINOL Tachykinin NK1 53% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2A DILTIAZEM Serotonin 5-HT2A 53% NoneNone NoneNone View
cholinergic receptor, muscarinic 5 TERFENADINE Muscarinic M5 53% NoneNone NoneNone View
cholinergic receptor, muscarinic 3 HYDROXYCHLOROQUINE Muscarinic M3 53% NoneNone NoneNone View
melanocortin 5 receptor TERFENADINE Melanocortin MC5 53% NoneNone NoneNone View
Cytochrom P450-2D6 monooxygenase DAUNORUBICIN CYP450-2D6 Inhibition 53% NoneNone NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) WARFARIN CYP450-2C9 Inhibition 53% NoneNone NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 WARFARIN CYP450-2C9 Inhibition 53% NoneNone NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) CYPROTERONE ACETATE CYP450-2C9 Inhibition 53% NoneNone NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 CYPROTERONE ACETATE CYP450-2C9 Inhibition 53% NoneNone NoneNone View
Cytochrom P450-2C19 monooxygenase PANTOPRAZOLE CYP450-2C19 Inhibition 53% NoneNone NoneNone View
mu-opioid receptor MOR CLOSANTEL Opiate mu 53% NoneNone NoneNone View
adrenergic receptor, beta 3 BITHIONOL Adrenergic beta3 53% NoneNone NoneNone View
adrenergic receptor, alpha 1d (Non-specific probe) DIPHENIDOL Adrenergic alpha1D 53% NoneNone NoneNone View
dopamine receptor D4 DOBUTAMINE Dopamine D4.2 53% NoneNone NoneNone View
mitogen activated protein kinase 1 COBALT(II) ACETYLACETONATE Protein Serine/Threonine Kinase, ERK2 53% NoneNone NoneNone View
mitogen-activated protein kinase 1 COBALT(II) ACETYLACETONATE Protein Serine/Threonine Kinase, ERK2 53% NoneNone NoneNone View
Cytochrom P450-2D6 monooxygenase DIHYDROERGOCRISTINE MESYLATE CYP450-2D6 Inhibition 53% NoneNone NoneNone View
thromboxane A synthase 1 DIHYDROERGOCRISTINE MESYLATE Thromboxane Synthetase 53% NoneNone NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) DIHYDROERGOCRISTINE MESYLATE Thromboxane Synthetase 53% NoneNone NoneNone View
acetylcholinesterase (YT blood group) TERBINAFINE Acetylcholinesterase 53% NoneNone NoneNone View
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase TERBINAFINE Acetylcholinesterase 53% NoneNone NoneNone View
acetylcholinesterase TERBINAFINE Acetylcholinesterase 53% NoneNone NoneNone View
mu-opioid receptor MOR PAROXETINE Opiate mu 53% NoneNone NoneNone View
cannabinoid receptor 1 (brain) PAROXETINE Cannabinoid CB1 53% NoneNone NoneNone View
adrenergic receptor, alpha 2a DESLORATADINE Adrenergic alpha2A 53% NoneNone NoneNone View
adrenergic receptor, alpha 2a PROPAFENONE Adrenergic alpha2A 53% NoneNone NoneNone View
adrenergic receptor, alpha 2a TACRINE Imidazoline I2, Central 53% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) TACRINE Imidazoline I2, Central 53% NoneNone NoneNone View
aldo-keto reductase family 1, member B4 (aldose reductase) ROSIGLITAZONE Aldose Reductase 53% NoneNone NoneNone View
aldo-keto reductase family 1, member B1 (aldose reductase) ROSIGLITAZONE Aldose Reductase 53% NoneNone NoneNone View
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) ROSIGLITAZONE Aldose Reductase 53% NoneNone NoneNone View
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) ROSIGLITAZONE Aldose Reductase 53% NoneNone NoneNone View
opioid receptor, sigma 1 METERGOLINE Sigma1 53% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 PROCHLORPERAZINE Calcium Channel Type L, Benzothiazepine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 PROCHLORPERAZINE Calcium Channel Type L, Benzothiazepine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 PROCHLORPERAZINE Calcium Channel Type L, Benzothiazepine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 PROCHLORPERAZINE Calcium Channel Type L, Benzothiazepine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 PROCHLORPERAZINE Calcium Channel Type L, Benzothiazepine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 PROCHLORPERAZINE Calcium Channel Type L, Benzothiazepine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 PROCHLORPERAZINE Calcium Channel Type L, Benzothiazepine 53% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta DIMENHYDRINATE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type 10, alpha polypeptide DIMENHYDRINATE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha polypeptide DIMENHYDRINATE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha polypeptide DIMENHYDRINATE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta DIMENHYDRINATE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha DIMENHYDRINATE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 gamma DIMENHYDRINATE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 beta DIMENHYDRINATE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide DIMENHYDRINATE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha DIMENHYDRINATE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, gamma DIMENHYDRINATE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, delta DIMENHYDRINATE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) DIMENHYDRINATE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha DIMENHYDRINATE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type X, alpha DIMENHYDRINATE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha DIMENHYDRINATE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage gated, type VIII, alpha DIMENHYDRINATE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha DIMENHYDRINATE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) DIMENHYDRINATE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta DIMENHYDRINATE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha DIMENHYDRINATE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type III, alpha DIMENHYDRINATE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta DIMENHYDRINATE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type II, alpha 2 DIMENHYDRINATE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta DIMENHYDRINATE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha DIMENHYDRINATE Sodium Channel, Site 2 52% NoneNone NoneNone View
Sigma-2 Receptor LEVOBUNOLOL Sigma2 52% NoneNone NoneNone View
5-hydroxytryptamine receptor 6 FLUNARIZINE Serotonin 5-HT6 52% NoneNone NoneNone View
cholinergic receptor, muscarinic 1 4-NONYLPHENOL Muscarinic M1 52% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B 1,3-DIPHENYLGUANIDINE Glutamate, NMDA, Phencyclidine 52% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl D-aspartate 2D 1,3-DIPHENYLGUANIDINE Glutamate, NMDA, Phencyclidine 52% NoneNone NoneNone View
glutamate receptor, ionotropic, NMDA2C 1,3-DIPHENYLGUANIDINE Glutamate, NMDA, Phencyclidine 52% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl D-aspartate 2B 1,3-DIPHENYLGUANIDINE Glutamate, NMDA, Phencyclidine 52% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl D-aspartate 2A 1,3-DIPHENYLGUANIDINE Glutamate, NMDA, Phencyclidine 52% NoneNone NoneNone View
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) 1,3-DIPHENYLGUANIDINE Glutamate, NMDA, Phencyclidine 52% NoneNone NoneNone View
cytochrome P450, family 3, subfamily a, polypeptide 13 HARRINGTONINE CYP450-3A4 Inhibition 52% NoneNone NoneNone View
cytochrome P450, family 3, subfamily a, polypeptide 13 PUROMYCIN CYP450-3A4 Inhibition 52% NoneNone NoneNone View
cytochrome P450, family 3, subfamily a, polypeptide 13 QUETIAPINE CYP450-3A4 Inhibition 52% NoneNone NoneNone View
Cytochrom P450-2D6 monooxygenase BUFLOMEDIL CYP450-2D6 Inhibition 52% NoneNone NoneNone View
Cytochrom P450-2D6 monooxygenase PRIMAQUINE CYP450-2D6 Inhibition 52% NoneNone NoneNone View
Cytochrom P450-2D6 monooxygenase RIMANTADINE CYP450-2D6 Inhibition 52% NoneNone NoneNone View
Cytochrom P450-2C19 monooxygenase BROMHEXINE CYP450-2C19 Inhibition 52% NoneNone NoneNone View
Cytochrom P450-2C19 monooxygenase PERGOLIDE CYP450-2C19 Inhibition 52% NoneNone NoneNone View
Cytochrom P450-2C19 monooxygenase RABEPRAZOLE CYP450-2C19 Inhibition 52% NoneNone NoneNone View
adrenergic receptor, alpha 1d (Non-specific probe) BERBERINE CHLORIDE Adrenergic alpha1D 52% NoneNone NoneNone View
adenosine A1 receptor AMINOPHYLLINE Adenosine A1 52% NoneNone NoneNone View
matrix metallopeptidase 9 PRIMAQUINE Protease, Matrix Metalloprotease-9 (MMP-9) 51% NoneNone NoneNone View
matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) PRIMAQUINE Protease, Matrix Metalloprotease-9 (MMP-9) 51% NoneNone NoneNone View
acetylcholinesterase (YT blood group) CARMOFUR Acetylcholinesterase 51% NoneNone NoneNone View
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase CARMOFUR Acetylcholinesterase 51% NoneNone NoneNone View
acetylcholinesterase CARMOFUR Acetylcholinesterase 51% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 LACIDIPINE Calcium Channel Type L, Phenylalkylamine 51% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 LACIDIPINE Calcium Channel Type L, Phenylalkylamine 51% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 LACIDIPINE Calcium Channel Type L, Phenylalkylamine 51% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 LACIDIPINE Calcium Channel Type L, Phenylalkylamine 51% NoneNone NoneNone View
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) AMANTADINE Glutamate, NMDA, Phencyclidine 51% 31.983uM 21.666uM View
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B AMANTADINE Glutamate, NMDA, Phencyclidine 51% 31.983uM 21.666uM View
adrenergic receptor, beta 2 TIRILAZAD Adrenergic beta2 51% 22.659uM 15.578uM View
cholinergic receptor, muscarinic 3 ALPHA-NAPHTHOFLAVONE Muscarinic M3 51% NoneNone NoneNone View
phosphodiesterase 5A, cGMP-specific COBALT (II) CHLORIDE Phosphodiesterase PDE5 51% NoneNone NoneNone View
phosphodiesterase 5A, cGMP-specific COBALT (II) CHLORIDE Phosphodiesterase PDE5 51% NoneNone NoneNone View
mitogen activated protein kinase 14 BENZO[E]PYRENE Protein Serine/Threonine Kinase, p38alpha 51% NoneNone NoneNone View
mitogen-activated protein kinase 14 BENZO[E]PYRENE Protein Serine/Threonine Kinase, p38alpha 51% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN Serotonin Transporter 51% NoneNone NoneNone View
Sigma-2 Receptor AMOXAPINE Sigma2 51% NoneNone NoneNone View
cytochrome P450, family 3, subfamily a, polypeptide 13 4-METHYLPYRAZOLE CYP450-3A4 Inhibition 51% NoneNone NoneNone View
Cytochrom P450-2D6 monooxygenase TOLPERISONE CYP450-2D6 Inhibition 51% NoneNone NoneNone View
Cytochrom P450-2C19 monooxygenase PERHEXILINE CYP450-2C19 Inhibition 51% NoneNone NoneNone View
Sigma-2 Receptor CYCLIZINE Sigma2 51% NoneNone NoneNone View
Sigma-2 Receptor HYDROXYPROGESTERONE Sigma2 51% NoneNone NoneNone View
5-hydroxytryptamine receptor 6 SULFAMETHAZINE Serotonin 5-HT6 51% NoneNone NoneNone View
platelet-activating factor receptor DILTIAZEM Platelet Activating Factor (PAF) 51% NoneNone NoneNone View
dopamine receptor D1A MONTELUKAST Dopamine D1 51% NoneNone NoneNone View
cytochrome P450, family 3, subfamily a, polypeptide 13 SERTRALINE CYP450-3A4 Inhibition 51% NoneNone NoneNone View
cytochrome P450, family 3, subfamily a, polypeptide 13 DOXAZOSIN CYP450-3A4 Inhibition 51% NoneNone NoneNone View
Cytochrom P450-2D6 monooxygenase MELATONIN CYP450-2D6 Inhibition 51% NoneNone NoneNone View
Cytochrom P450-2D6 monooxygenase DOBUTAMINE CYP450-2D6 Inhibition 51% NoneNone NoneNone View
Cytochrom P450-2C19 monooxygenase TANNIC ACID CYP450-2C19 Inhibition 51% NoneNone NoneNone View
A3 adenosine receptor IMATINIB Adenosine A3 51% NoneNone NoneNone View
acetylcholinesterase (YT blood group) FLUNARIZINE Acetylcholinesterase 51% NoneNone NoneNone View
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase FLUNARIZINE Acetylcholinesterase 51% NoneNone NoneNone View
acetylcholinesterase FLUNARIZINE Acetylcholinesterase 51% NoneNone NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) 3,3',4',5-TETRACHLOROSALICYLANILIDE Protein Tyrosine Kinase, HER2 Receptor 51% NoneNone NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) 3,3',4',5-TETRACHLOROSALICYLANILIDE Protein Tyrosine Kinase, HER2 Receptor 51% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 ETHYLESTRENOL Dopamine Transporter 51% NoneNone NoneNone View
A3 adenosine receptor AMITRAZ Adenosine A3 51% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 GRAMICIDIN Serotonin Transporter 51% NoneNone NoneNone View
tachykinin receptor 1 GRAMICIDIN Tachykinin NK1 51% NoneNone NoneNone View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 KITASAMYCIN Adenosine Transporter 51% NoneNone NoneNone View
concentrative Na+ nucleoside cotransporter (DBSS) KITASAMYCIN Adenosine Transporter 51% NoneNone NoneNone View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 KITASAMYCIN Adenosine Transporter 51% NoneNone NoneNone View
adenine nucleotide translocase (DBSS) (Non-specific probe) KITASAMYCIN Adenosine Transporter 51% NoneNone NoneNone View
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 KITASAMYCIN Adenosine Transporter 51% NoneNone NoneNone View
tachykinin receptor 2 IVERMECTIN Tachykinin NK2 51% NoneNone NoneNone View
Cytochrom P450-2D6 monooxygenase SPIRADOLINE CYP450-2D6 Inhibition 51% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta ERGOTAMINE Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel associated protein 1 ERGOTAMINE Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel associated protein 2 ERGOTAMINE Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta ERGOTAMINE Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha ERGOTAMINE Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha ERGOTAMINE Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha ERGOTAMINE Sodium Channel, Site 2 51% NoneNone NoneNone View
amiloride-sensitive cation channel 5, intestinal ERGOTAMINE Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta ERGOTAMINE Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type VIII, alpha polypeptide ERGOTAMINE Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha ERGOTAMINE Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta ERGOTAMINE Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type 10, alpha polypeptide ERGOTAMINE Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha polypeptide ERGOTAMINE Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha polypeptide ERGOTAMINE Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta ERGOTAMINE Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha ERGOTAMINE Sodium Channel, Site 2 51% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 GUANETHIDINE Calcium Channel Type L, Benzothiazepine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit GUANETHIDINE Calcium Channel Type L, Benzothiazepine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit GUANETHIDINE Calcium Channel Type L, Benzothiazepine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit GUANETHIDINE Calcium Channel Type L, Benzothiazepine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit GUANETHIDINE Calcium Channel Type L, Benzothiazepine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit GUANETHIDINE Calcium Channel Type L, Benzothiazepine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit GUANETHIDINE Calcium Channel Type L, Benzothiazepine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit GUANETHIDINE Calcium Channel Type L, Benzothiazepine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit GUANETHIDINE Calcium Channel Type L, Benzothiazepine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit GUANETHIDINE Calcium Channel Type L, Benzothiazepine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit GUANETHIDINE Calcium Channel Type L, Benzothiazepine 54% NoneNone NoneNone View
potassium voltage-gated channel, subfamily H, member 8 PENTAMIDINE Potassium Channel HERG 54% 15.7215uM 12.8802uM View